-
Prime Medicine's (PRME) "Outperform" Rating Reiterated at Wedbush
Источник: Buzz FX / 19 мар 2025 21:21:17 America/Chicago
Prime Medicine's (PRME) "Outperform" Rating Reiterated at Wedbush Written by MarketBeat March 19, 2025 Share Link copied to clipboard. Remove Ads Prime Medicine ( NYSE:PRME - Get Free Report ) 's stock had its "outperform" rating reiterated
Read more...